Ortiz Fernanda, Paavonen Timo, Törnroth Tom, Koskinen Petri, Finne Patrik, Salmela Kaija, Kyllönen Lauri, Grönhagen-Riska Carola, Honkanen Eero
Helsinki University Central Hospital, Kasarmikatu 11-13, 00029 HUCH, Helsinki, Finland.
J Am Soc Nephrol. 2005 Mar;16(3):817-24. doi: 10.1681/ASN.2004060475. Epub 2005 Feb 2.
The objective of this study was to analyze factors that are involved in the progression of renal allograft damage in the first 6 mo after transplantation. Donor and 6-mo protocol biopsies of 83 patients who received a renal transplant were classified using the Chronic Allograft Damage Index (CADI). Histologic changes were compared and correlated to clinical parameters at transplantation, at 6 mo, and annually over 2 yr. All CADI components increased significantly in the 6-mo posttransplantation period, except chronic vascular changes and the percentage of glomerulosclerosis. Total cholesterol and LDL- cholesterol at the time of biopsy correlated positively with mesangial matrix increase, and HDL cholesterol correlated negatively with vascular intima increase. High BP at biopsy was associated with tubular atrophy. Diastolic BP at biopsy correlated with 6-mo CADI (CADI-6). Patients with diastolic BP > or =85 mmHg at biopsy had a higher difference between CADI score in protocol biopsies and CADI score in donor biopsies (DeltaCADI) and higher creatinine at 1 and 2 yr. CADI in donor biopsies (CADI-0) >1 was more frequently found in older (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.01 to 1.14) and nontraumatic dead donors (OR, 3.89; 95% CI, 1.13 to 13.33). CADI-6 >3 was more frequently found in those with CADI-0 >1 (OR, 3.82; 95% CI, 1.19 to 12.21), older donors (OR, 1.05; 95% CI, 1.01 to 1.10), and number of AB mismatches (OR, 2.36; 95% CI, 1.09 to 5.10). CADI-0, CADI-6, and DeltaCADI correlated significantly with serum creatinine at hospital discharge, at 6 mo, and at 2 yr. DeltaCADI was affected by initial percentage of glomerulosclerosis (OR, 1.10; 95% CI, 1.02 to 1.19) and creatinine at hospital discharge (OR, 1.01; 95% CI, 1.00 to 1.02). Donor-related as well as nonimmunologic factors, such as hypertension and dyslipidemia, are associated with increased risk for renal allograft damage progression.
本研究的目的是分析肾移植术后前6个月内参与同种异体肾移植损伤进展的因素。使用慢性移植肾损伤指数(CADI)对83例接受肾移植患者的供体活检组织和术后6个月的方案活检组织进行分类。比较组织学变化,并将其与移植时、6个月时以及2年期间每年的临床参数进行关联分析。除慢性血管变化和肾小球硬化百分比外,所有CADI组分在移植后6个月期间均显著增加。活检时的总胆固醇和低密度脂蛋白胆固醇与系膜基质增加呈正相关,高密度脂蛋白胆固醇与血管内膜增加呈负相关。活检时的高血压与肾小管萎缩相关。活检时的舒张压与6个月时的CADI(CADI-6)相关。活检时舒张压≥85 mmHg的患者,方案活检的CADI评分与供体活检的CADI评分之间的差异(ΔCADI)更大,且1年和2年时的肌酐水平更高。供体活检时的CADI(CADI-0)>1在年龄较大的供体(优势比[OR],1.07;95%置信区间[CI],1.01至1.14)和非创伤性死亡供体中更常见(OR,3.89;95%CI,1.13至13.33)。CADI-6>3在CADI-0>1的患者(OR,3.82;95%CI,1.19至12.21)、年龄较大的供体(OR,1.05;95%CI,1.01至1.10)以及AB错配数较多的患者中更常见(OR,2.36;95%CI,1.09至5.10)。CADI-0、CADI-6和ΔCADI与出院时、6个月时和2年时的血清肌酐显著相关。ΔCADI受肾小球硬化初始百分比(OR,1.10;95%CI,1.02至1.19)和出院时肌酐水平(OR,1.01;95%CI,1.00至1.02)的影响。供体相关因素以及非免疫因素,如高血压和血脂异常,与同种异体肾移植损伤进展风险增加相关。